This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Applied Genetic Technologies 과거 수익 실적
과거 기준 확인 0/6
주요 정보
-39.8%
수익 성장률
-21.1%
EPS 성장률
| Biotechs 산업 성장 | 17.0% |
| 매출 성장률 | -57.4% |
| 자기자본 수익률 | -398.0% |
| 순이익 | -21,610.5% |
| 최근 수익 업데이트 | 30 Sep 2022 |
최근 과거 실적 업데이트
Recent updates
AGTC receives positive feedback from FDA for manufacturing facility
Jul 26Applied Genetic Technologies proposes stock offering to fund clinical trials
Jul 12Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022
Jan 12An Assessment Of Applied Genetic Technologies Corporation
Dec 14Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk
Jul 15Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?
May 21
Applied Genetic trades lower after announcing the departure of chief scientific officer
Apr 26What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
Feb 05
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?
Jan 06What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 11Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic
Nov 11수익 및 비용 분석
수익 및 비용 분석
Applied Genetic Technologies 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Sep 22 | 0 | -70 | 17 | 28 |
| 30 Jun 22 | 0 | -69 | 17 | 28 |
| 31 Mar 22 | 1 | -63 | 17 | 25 |
| 31 Dec 21 | 1 | -63 | 16 | 23 |
| 30 Sep 21 | 1 | -60 | 15 | 22 |
| 30 Jun 21 | 1 | -58 | 15 | 21 |
| 31 Mar 21 | 0 | -60 | 14 | 21 |
| 31 Dec 20 | 0 | -57 | 14 | 21 |
| 30 Sep 20 | 2 | -50 | 14 | 27 |
| 30 Jun 20 | 2 | -46 | 14 | 21 |
| 31 Mar 20 | 3 | -42 | 13 | 21 |
| 31 Dec 19 | 24 | -19 | 13 | 29 |
| 30 Sep 19 | 28 | -15 | 13 | 20 |
| 30 Jun 19 | 42 | -2 | 13 | 19 |
| 31 Mar 19 | 47 | 2 | 13 | 2 |
| 31 Dec 18 | 29 | -18 | 14 | 1 |
| 30 Sep 18 | 28 | -19 | 14 | 5 |
| 30 Jun 18 | 24 | -21 | 14 | 0 |
| 31 Mar 18 | 27 | -18 | 14 | 27 |
| 31 Dec 17 | 32 | -11 | 13 | 15 |
| 30 Sep 17 | 38 | -4 | 12 | 15 |
| 30 Jun 17 | 39 | 0 | 11 | 15 |
| 31 Mar 17 | 43 | 6 | 11 | 11 |
| 31 Dec 16 | 47 | 10 | 10 | 11 |
| 30 Sep 16 | 48 | 11 | 10 | 11 |
| 30 Jun 16 | 47 | -1 | 10 | 11 |
| 31 Mar 16 | 36 | -12 | 10 | 0 |
| 31 Dec 15 | 24 | -20 | 11 | 0 |
양질의 수익: AGTC is currently unprofitable.
이익 마진 증가: AGTC is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: AGTC is unprofitable, and losses have increased over the past 5 years at a rate of 39.8% per year.
성장 가속화: Unable to compare AGTC's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: AGTC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (60.8%).
자기자본 수익률
높은 ROE: AGTC has a negative Return on Equity (-398.02%), as it is currently unprofitable.